Severe Anemia Due to Parvovirus Infection Following Treatment with Rituximab in a Pediatric Kidney Transplant Recipient : Anemia after Treatment of Rituximab in Kidney Recipient Patient

Rituximab (RTX), a monoclonal antibody against the B-cell marker CD20, is commonly used as a treatment for antibody-mediated diseases or B-lymphocyte-mediated diseases. Destruction of B cells may reverse the disease course in many conditions; however, patients who are treated with RTX cannot respond...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Seung Yun Kim, Hyoung Jin Lee, Eujin Park, Yo Han Ahn, Il-Soo Ha, Hae Il Cheong, Hee Gyung Kang
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Korean Society of Pediatric Nephrology 2015-10-01
Edice:	Childhood Kidney Diseases
Témata:	rituximab parvovirus kidney transplantation prca anemia
On-line přístup:	http://www.chikd.org/upload/ckd-19-2-176.pdf
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!